慢性心力衰竭的运动能力

G. Mentzer, A. Auseon
{"title":"慢性心力衰竭的运动能力","authors":"G. Mentzer, A. Auseon","doi":"10.15420/USC.2012.9.1.57","DOIUrl":null,"url":null,"abstract":"of the primary prevention of cardiovascular (CV) disease. However, more emphasis needs to be placed on physicians identifying those at risk of HF who require intensified primary prevention practices and advanced therapies to prevent progression. In addition, this would need to include an assessment of exercise capacity, with each patient given a specific exercise prescription. 7 This could range from a conversation during an office visit to more advanced screening for high-risk individuals, with the selection of an exercise test to further assess functional capacity and the need for therapy. Physicians also need to be aware of the patient’s current level of conditioning, factors that predict safety in exercising, and proven methods to increase exercise adherence among patients. In the evaluation of HF, clinical assessment of dyspnea, fatigue, and exertional symptoms have been used for diagnosis and staging. 2 Exercise capacity has also been used to determine prognosis because it can be quantified objectively with a six-minute walk test, treadmill or cycle stress test, and cardiopulmonary exercise testing (CPET). 8–13 The limiting component in exercise capacity for those with HF is impaired Abstract Heart failure (HF) affects more than 5 million people and has an increasing incidence and cost burden. Patients note symptoms of dyspnea and fatigue that result in a decreased quality of life, which has not drastically improved over the past decades despite advances in therapies. The assessment of exercise capacity can provide information regarding patient diagnosis and prognosis, while doubling as a potential future therapy. Clinically, there is acceptance that exercise is safe in HF and can have a positive impact on morbidity and quality of life, although evidence for improvement in mortality is still lacking. Specific prescriptions for exercise training have not been developed because many variables and confounding factors have prevented research trials from demonstrating an ideal regimen. Physicians are becoming more aware of the indices and goals for HF patients in exercise testing and therapy to provide comprehensive cardiac care. It is further postulated that a combination of exercise training and pharmacologic therapy may eventually provide the most benefits to those suffering from HF.","PeriodicalId":74859,"journal":{"name":"Spring simulation conference (SpringSim)","volume":"30 1","pages":"57-60"},"PeriodicalIF":0.0000,"publicationDate":"2012-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Exercise Capacity in Chronic Heart Failure\",\"authors\":\"G. Mentzer, A. Auseon\",\"doi\":\"10.15420/USC.2012.9.1.57\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"of the primary prevention of cardiovascular (CV) disease. However, more emphasis needs to be placed on physicians identifying those at risk of HF who require intensified primary prevention practices and advanced therapies to prevent progression. In addition, this would need to include an assessment of exercise capacity, with each patient given a specific exercise prescription. 7 This could range from a conversation during an office visit to more advanced screening for high-risk individuals, with the selection of an exercise test to further assess functional capacity and the need for therapy. Physicians also need to be aware of the patient’s current level of conditioning, factors that predict safety in exercising, and proven methods to increase exercise adherence among patients. In the evaluation of HF, clinical assessment of dyspnea, fatigue, and exertional symptoms have been used for diagnosis and staging. 2 Exercise capacity has also been used to determine prognosis because it can be quantified objectively with a six-minute walk test, treadmill or cycle stress test, and cardiopulmonary exercise testing (CPET). 8–13 The limiting component in exercise capacity for those with HF is impaired Abstract Heart failure (HF) affects more than 5 million people and has an increasing incidence and cost burden. Patients note symptoms of dyspnea and fatigue that result in a decreased quality of life, which has not drastically improved over the past decades despite advances in therapies. The assessment of exercise capacity can provide information regarding patient diagnosis and prognosis, while doubling as a potential future therapy. Clinically, there is acceptance that exercise is safe in HF and can have a positive impact on morbidity and quality of life, although evidence for improvement in mortality is still lacking. Specific prescriptions for exercise training have not been developed because many variables and confounding factors have prevented research trials from demonstrating an ideal regimen. Physicians are becoming more aware of the indices and goals for HF patients in exercise testing and therapy to provide comprehensive cardiac care. It is further postulated that a combination of exercise training and pharmacologic therapy may eventually provide the most benefits to those suffering from HF.\",\"PeriodicalId\":74859,\"journal\":{\"name\":\"Spring simulation conference (SpringSim)\",\"volume\":\"30 1\",\"pages\":\"57-60\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-02-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Spring simulation conference (SpringSim)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15420/USC.2012.9.1.57\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Spring simulation conference (SpringSim)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/USC.2012.9.1.57","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

心血管(CV)疾病的一级预防然而,更需要强调的是,医生应该识别出那些有心衰风险的人,这些人需要加强初级预防措施和先进的治疗来防止病情发展。此外,这还需要包括对运动能力的评估,并为每位患者提供特定的运动处方。这可以从办公室访问期间的谈话到对高风险个体进行更高级的筛查,并选择运动测试来进一步评估功能能力和治疗需求。医生还需要了解患者当前的体能水平,预测运动安全性的因素,以及提高患者运动依从性的行之有效的方法。在评估心力衰竭时,临床评估呼吸困难、疲劳和劳累症状已被用于诊断和分期。2运动能力也被用来确定预后,因为它可以通过6分钟步行测试、跑步机或循环压力测试和心肺运动测试(CPET)客观量化。心力衰竭(HF)影响着超过500万人,其发病率和费用负担都在不断增加。患者注意到呼吸困难和疲劳的症状,导致生活质量下降,在过去的几十年里,尽管治疗取得了进步,但并没有显著改善。运动能力的评估可以提供有关患者诊断和预后的信息,同时也可以作为潜在的未来治疗方法。临床上,人们普遍认为运动对心衰患者是安全的,并且可以对发病率和生活质量产生积极影响,尽管仍缺乏改善死亡率的证据。运动训练的具体处方尚未开发,因为许多变量和混杂因素阻碍了研究试验证明理想的方案。医生越来越意识到心衰患者在运动试验和治疗中的指标和目标,以提供全面的心脏护理。进一步假设运动训练和药物治疗相结合可能最终为心衰患者提供最大的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Exercise Capacity in Chronic Heart Failure
of the primary prevention of cardiovascular (CV) disease. However, more emphasis needs to be placed on physicians identifying those at risk of HF who require intensified primary prevention practices and advanced therapies to prevent progression. In addition, this would need to include an assessment of exercise capacity, with each patient given a specific exercise prescription. 7 This could range from a conversation during an office visit to more advanced screening for high-risk individuals, with the selection of an exercise test to further assess functional capacity and the need for therapy. Physicians also need to be aware of the patient’s current level of conditioning, factors that predict safety in exercising, and proven methods to increase exercise adherence among patients. In the evaluation of HF, clinical assessment of dyspnea, fatigue, and exertional symptoms have been used for diagnosis and staging. 2 Exercise capacity has also been used to determine prognosis because it can be quantified objectively with a six-minute walk test, treadmill or cycle stress test, and cardiopulmonary exercise testing (CPET). 8–13 The limiting component in exercise capacity for those with HF is impaired Abstract Heart failure (HF) affects more than 5 million people and has an increasing incidence and cost burden. Patients note symptoms of dyspnea and fatigue that result in a decreased quality of life, which has not drastically improved over the past decades despite advances in therapies. The assessment of exercise capacity can provide information regarding patient diagnosis and prognosis, while doubling as a potential future therapy. Clinically, there is acceptance that exercise is safe in HF and can have a positive impact on morbidity and quality of life, although evidence for improvement in mortality is still lacking. Specific prescriptions for exercise training have not been developed because many variables and confounding factors have prevented research trials from demonstrating an ideal regimen. Physicians are becoming more aware of the indices and goals for HF patients in exercise testing and therapy to provide comprehensive cardiac care. It is further postulated that a combination of exercise training and pharmacologic therapy may eventually provide the most benefits to those suffering from HF.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信